# Safety and Tolerability of SYNB1618 in Healthy Adult Volunteers and Adult Subjects With Phenylketonuria

> **NCT03516487** · PHASE1,PHASE2 · COMPLETED · sponsor: **Synlogic** · enrollment: 70 (actual)

## Conditions studied

- Phenylketonuria
- Healthy

## Interventions

- **DRUG:** SYNB1618
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03516487
- **Lead sponsor:** Synlogic
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-17
- **Primary completion:** 2019-06-21
- **Final completion:** 2019-06-21
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2021-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03516487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03516487, "Safety and Tolerability of SYNB1618 in Healthy Adult Volunteers and Adult Subjects With Phenylketonuria". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03516487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*